Data sourced from SEC EDGAR filingsCompiled by Free Startup Funding DatabaseLast updated: 2022-02-07
SEC Form D Verified2 Funds Tracked

Lrvhealth

Venture Capital Firm | Contact, Fund History & Investment Focus

BOSTON, MA
Visit Website
Stage Focus

series-a

Funds Tracked

2

Total Raised

$303M

Latest Fund

LRVHealth II, LP

Feb 2022 · $200M

How to Contact Lrvhealth

Official Contact Channels

www.lrvhealth.com

General Partners

William R. Cowen; Word D. Peake; Keith J. Figlioli; Keith D. Figlioli

Best Practices for Reaching Out

  • Research their fund history to understand their investment thesis before reaching out
  • Connect with their team on LinkedIn for warm introductions when possible
  • Keep your initial outreach concise with clear traction metrics

Fund History

LRVHealth II, LP

Feb 2022 · series-a

$200M

LRVHealth, LP

Jan 2018 · series-a

$103M

Massachusetts's Venture Capital Ecosystem

Massachusetts, centered around Boston and Cambridge, is the nation's biotech and life sciences capital with world-class research institutions.

Biotech and life sciences hub
MIT and Harvard ecosystem
Deep tech innovation
Strong healthcare presence
Explore all VC firms in Massachusetts

Frequently Asked Questions

How do I contact Lrvhealth?

Visit Lrvhealth's official website to find their contact information.

How many funds has Lrvhealth raised?

Lrvhealth has raised 2 tracked funds, totaling $303M in tracked capital.

What stage does Lrvhealth invest in?

Lrvhealth focuses on series-a investments.

Where is Lrvhealth located?

Lrvhealth is headquartered in BOSTON, MA.

Firm Details

First FilingJan 2018
Latest FilingFeb 2022

Similar Firms in Massachusetts

Awareness Venture

pre-seed

12 FLAGS Consumer

seed

82VS Seed

seed

CRCP AV

pre-seed

DHVP

pre-seed

116 Street Ventures

unknown

View all Massachusetts VCs →

Explore More

VC Firms A-Z DirectoryBusiness GrantsStartup AcceleratorsAngel Networks

Data Sources: SEC EDGAR filings, company disclosures, and verified public records.

Last updated: Feb 7, 2022